Literature DB >> 10447519

Cytokine secretion patterns in twins discordant for Type I diabetes.

B A Kallmann1, E F Lampeter, P Hanifi-Moghaddam, M Hawa, R D Leslie, H Kolb.   

Abstract

AIMS/HYPOTHESIS: The search for T-cell reactions that are associated with disease in Type I (insulin-dependent) diabetes mellitus is severely hampered because control groups cannot be matched for relevant immune response genes. We therefore compared T-cell responses between identical twins discordant for Type I diabetes.
METHODS: Pairs of monozygotic twins (n = 17) discordant for Type I diabetes were studied. Cultures were set up from whole blood immediately after sampling and cells were challenged with human recombinant hsp60, with the mitogen phytohaemagglutinin or with the staphylococcal superantigen. Supernatants were removed after 48 or 96 h and analysed for T-helper1 type cytokines interferon-gamma, TNFalpha and T-helper2 type cytokines IL-4, IL-10 by sandwich-ELISA.
RESULTS: The height of the T-helper1 type cytokine response to hsp60, phytohaemagglutinin or staphylococcal enterotoxin B did not show disease association, i. e. it was similar between discordant twins. In contrast, the production of T-helper2 type cytokines differed between discordant twins. The IL-10 response to hsp60 was higher in twins at low disease risk (islet cell antibody-negative) than in their diabetic cotwins (p < 0.01), as was the IL-4 response to phytohaemagglutinin (p < 0.05). No difference was seen in the cytokine response between islet cell antibody-positive twins and their diabetic cotwins. CONCLUSIONS/
INTERPRETATION: The data indicate an association between T-helper2 type cytokine secretion patterns and disease or disease risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447519     DOI: 10.1007/s001250051274

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

Review 1.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Redox status and immune function in type I diabetes families.

Authors:  E Matteucci; G Malvaldi; F Fagnani; I Evangelista; O Giampietro
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

3.  Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.

Authors:  R Rodrigues dos Santos Júnior; A Sartori; V L Deperon Bonato; A A M Coelho Castelo; C A Vilella; R L Zollner; C Lopes Silva
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

4.  IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.

Authors:  S Hoppu; T Härkönen; M S Ronkainen; S Simell; A Hekkala; A Toivonen; J Ilonen; O Simell; M Knip
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

5.  Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.

Authors:  Rémi J Creusot; Shahriar S Yaghoubi; Keiichi Kodama; Demi N Dang; Vu H Dang; Karine Breckpot; Kris Thielemans; Sanjiv S Gambhir; C Garrison Fathman
Journal:  Clin Immunol       Date:  2008-03-12       Impact factor: 3.969

6.  Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient.

Authors:  Urs Christen; Dirk Benke; Tom Wolfe; Evelyn Rodrigo; Antje Rhode; Anna C Hughes; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

7.  Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.

Authors:  B Z Alizadeh; P Hanifi-Moghaddam; P Eerligh; A R van der Slik; H Kolb; A V Kharagjitsingh; A M Pereira Arias; M Ronkainen; M Knip; R Bonfanti; E Bonifacio; D Devendra; T Wilkin; M J Giphart; B P C Koeleman; R Nolsøe; T Mandrup Poulsen; N C Schloot; B O Roep
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.